Related Experiment Video
Updated: Jul 7, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
[Chronic obstructive pulmonary disease: from pathogenesis to treatment]
1Abteilung für Pulmonologie, Universitätsklinikum Giessen und Marburg, Standort Marburg, Baldingerstrasse 1, 35042 Marburg. koczulla@uni-marburg.de
Deutsche Medizinische Wochenschrift (1946)
|February 28, 2008
Summary
Chronic obstructive pulmonary disease (COPD) involves airway inflammation and impaired airflow, potentially linked to oxidative stress and protease-antiprotease imbalance. Systemic effects are increasingly recognized, driving new therapeutic strategies for improved patient outcomes.
Area of Science:
- Pulmonary Medicine
- Pathophysiology
- Inflammation Research
Context:
- Chronic obstructive pulmonary disease (COPD) is characterized by airflow limitation and abnormal lung inflammation.
- Inhaled irritants trigger small airway inflammation, a key factor in COPD pathogenesis.
- Oxidative stress and an imbalance between proteases and antiproteases contribute to lung emphysema.
Purpose:
- To explore the pathogenetic factors in COPD, including inflammation, oxidative stress, and protease-antiprotease imbalance.
- To investigate the role of apoptosis in alveolar cell loss and emphysema development.
- To highlight the systemic manifestations of COPD and their implications for treatment.
Summary:
- COPD pathogenesis involves airway inflammation due to inhaled irritants, oxidative stress, and a disrupted protease-antiprotease balance leading to emphysema.
- Apoptosis of alveolar cells is also implicated in emphysema development.
- Systemic inflammation is common in COPD, with associated cardiovascular, neurological, psychiatric, musculoskeletal, and endocrine complications.
Impact:
- Understanding these mechanisms can inform the development of novel therapeutic strategies for COPD.
- Addressing systemic consequences may improve disease control, reduce morbidity, and enhance patients' quality of life.
- This research emphasizes a holistic approach to managing COPD, considering both pulmonary and systemic aspects.
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.